| 000 | 01714 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517174027.0 | ||
| 264 | 0 | _c20180612 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1757-4684 | ||
| 024 | 7 |
_a10.15252/emmm.201707814 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrippa, Stefania | |
| 245 | 0 | 0 |
_aMutant _h[electronic resource] |
| 260 |
_bEMBO molecular medicine _c11 2017 |
||
| 300 |
_a1589-1604 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aFetus _xmetabolism |
| 650 | 0 | 4 |
_aGluconeogenesis _xgenetics |
| 650 | 0 | 4 |
_aGlucose Transporter Type 3 _xmetabolism |
| 650 | 0 | 4 |
_aGlycolysis _xgenetics |
| 650 | 0 | 4 |
_aHepatoblastoma _xmetabolism |
| 650 | 0 | 4 |
_aHexokinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factor 4 _xgenetics |
| 650 | 0 | 4 |
_abeta Catenin _xantagonists & inhibitors |
| 700 | 1 | _aAncey, Pierre-Benoit | |
| 700 | 1 | _aVazquez, Jessica | |
| 700 | 1 | _aAngelino, Paolo | |
| 700 | 1 | _aRougemont, Anne-Laure | |
| 700 | 1 | _aGuettier, Catherine | |
| 700 | 1 | _aZoete, Vincent | |
| 700 | 1 | _aDelorenzi, Mauro | |
| 700 | 1 | _aMichielin, Olivier | |
| 700 | 1 | _aMeylan, Etienne | |
| 773 | 0 |
_tEMBO molecular medicine _gvol. 9 _gno. 11 _gp. 1589-1604 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.15252/emmm.201707814 _zAvailable from publisher's website |
| 999 |
_c27578449 _d27578449 |
||